Tag: therapy-for

Two case studies provide potential new avenue for treatment of kidney cancer

| April 8, 2015 | 0 Comments

UT Southwestern Medical Center Kidney Cancer Program investigators have published what is believed to be the first reported successful use of stereotactic body radiation therapy for an often deadly complication of kidney cancer.

Continue Reading

University Hospitals doctors say the process allows differing levels of radiation

| April 6, 2015 | 0 Comments

University Hospitals is giving a boost to treatment for one of the most common forms of cancer affecting men. They’re using a new technology designed to improve radiation therapy for prostate cancer patients

Continue Reading

Concurrent chemoradiation treatment at high-volume facilities improves survival for NSCLC

| March 11, 2015 | 0 Comments

Patients treated with definitive concurrent chemotherapy and radiation therapy for stage III non-small cell lung cancer have longer overall survival when treated by highly experienced facilities, whether or not they are academic or community cancer centers.

Continue Reading

HRT 'increases ovarian cancer risk'

| February 13, 2015 | 0 Comments

Taking hormone replacement therapy for even short periods of time can increase the risk of ovarian cancer, a study shows.

Continue Reading

HRT 'increases ovarian cancer risk'

| February 13, 2015 | 0 Comments

Taking hormone replacement therapy for even short periods of time can increase the risk of ovarian cancer, analysis of 52 studies finds.

Continue Reading

Pfizer Receives U.S. FDA Accelerated Approval of IBRANCE® (palbociclib)

| February 3, 2015 | 0 Comments

NEW YORK–(BUSINESS WIRE)–Pfizer Inc. today announced the U.S. Food and Drug Administration (FDA) has granted accelerated approval of IBRANCE® (palbociclib), in combination with letrozole, for the treatment of postmenopausal women with estrogen receptor-positive, human epidermal growth factor receptor 2-negative (ER+/HER2-) advanced breast cancer as initial endocrine-based therapy for their …

Continue Reading

Immune system may play a key role in viral therapy's effectiveness against tumors

| January 21, 2015 | 0 Comments

Viral therapy for childhood cancer could possibly improve if treatments such as chemotherapy do not first suppress patients' immune systems, according to new research findings. Research on mouse tumors resembling rhabdomyosarcoma, the most common soft tissue sarcoma in children, revealed that the immune system's T cells may be just as critical to fighting tumor cells as the viral therapy …

Continue Reading

Immune system may play a key role in viral therapy's effectiveness against tumors

| January 21, 2015 | 0 Comments

Viral therapy for childhood cancer could possibly improve if treatments such as chemotherapy do not first suppress patients’ immune systems, according to new research findings. Research on mouse tumors resembling rhabdomyosarcoma, the most common soft tissue sarcoma in children, revealed that the immune system’s T cells may be just as critical to fighting tumor cells as the viral therapy …

Continue Reading

Atterocor Expands Phase 1 Trial of ATR-101 to Additional Leading Adrenal Cancer Centers

| December 11, 2014 | 0 Comments

Atterocor, Inc., a company developing a novel therapy for adrenal cancer, today announced that the company has expanded its Phase 1 trial of ATR-101, an investigational therapy for the treatment of adrenocortical carcinoma , to include the National Cancer Institute in Bethesda, Maryland, H.

Continue Reading

Experience counts with radiation therapy for head and neck cancer, study shows

| December 8, 2014 | 0 Comments

( Ohio State University Wexner Medical Center ) Radiation therapy for head and neck cancer is highly complex, and a new study published in the Journal of Clinical Oncology with an accompanying editorial suggests that medical centers with more experience centers have better patient outcomes.

Continue Reading